Liquidia (NASDAQ:LQDA) Insider Jason Adair Sells 73,631 Shares

Posted by Brian Himes on Aug 26th, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) insider Jason Adair sold 73,631 shares of Liquidia stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $69.09, for a total transaction of $5,087,165.79. Following the completion of the sale, the insider directly owned 174,606 shares in the company, valued at $12,063,528.54. This trade represents a 29.66% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Jason Adair also recently made the following trade(s):

On Monday, July 27th, Jason Adair sold 688 shares of Liquidia stock. The shares were sold at an average price of $87.53, for a total value of $60,220.64.
On Monday, July 13th, Jason Adair sold 7,863 shares of Liquidia stock. The shares were sold at an average price of $71.51, for a total value of $562,283.13.

Liquidia Stock Performance

NASDAQ:LQDA opened at $70.49 on Wednesday. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. The business has a fifty day simple moving average of $79.31 and a two-hundred day simple moving average of $56.65. Liquidia Corporation has a 1 year low of $21.15 and a 1 year high of $93.61. The company has a market capitalization of $6.31 billion, a P/E ratio of 51.45 and a beta of 0.58.

Liquidia (NASDAQ:LQDA – Get Free Report) last issued its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.76 by ($0.02). The firm had revenue of $171.68 million during the quarter, compared to the consensus estimate of $168.48 million. Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The business’s quarterly revenue was up 1842.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned ($0.49) earnings per share. On average, analysts expect that Liquidia Corporation will post 2.57 earnings per share for the current year.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in shares of Liquidia by 4.7% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 37,681 shares of the company’s stock worth $556,000 after buying an additional 1,700 shares in the last quarter. Goldman Sachs Group Inc. grew its stake in Liquidia by 10.7% during the first quarter. Goldman Sachs Group Inc. now owns 861,231 shares of the company’s stock valued at $12,703,000 after acquiring an additional 82,955 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its stake in Liquidia by 15.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 121,756 shares of the company’s stock valued at $1,796,000 after acquiring an additional 16,022 shares in the last quarter. Creative Planning increased its holdings in Liquidia by 40.7% during the 2nd quarter. Creative Planning now owns 26,840 shares of the company’s stock worth $334,000 after acquiring an additional 7,765 shares during the period. Finally, Legal & General Group Plc increased its holdings in Liquidia by 13.4% during the 2nd quarter. Legal & General Group Plc now owns 94,152 shares of the company’s stock worth $1,174,000 after acquiring an additional 11,111 shares during the period. Institutional investors own 64.54% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on LQDA. Zacks Research lowered shares of Liquidia from a “strong-buy” rating to a “hold” rating in a research report on Thursday, August 13th. Jefferies Financial Group reissued a “buy” rating and issued a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. Piper Sandler set a $129.00 price target on shares of Liquidia in a research note on Friday, July 24th. Wall Street Zen downgraded shares of Liquidia from a “strong-buy” rating to a “buy” rating in a report on Saturday, June 27th. Finally, Wells Fargo & Company raised their price objective on shares of Liquidia from $62.00 to $108.00 and gave the stock an “overweight” rating in a report on Thursday, August 13th. One equities research analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating, three have assigned a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Liquidia currently has an average rating of “Hold” and a consensus target price of $98.08.

Read Our Latest Stock Report on Liquidia

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).